| Human papillomavirus vaccination in low-and middle-income countries: progression, barriers, and future prospective N Ebrahimi, Z Yousefi, G Khosravi, FE Malayeri, M Golabi, M Askarzadeh, ... Frontiers in Immunology 14, 1150238, 2023 | 56 | 2023 |
| Aptamer-conjugated carbon-based nanomaterials for cancer and bacteria theranostics: A review S Sargazi, ER Simge, A Mobashar, SS Gelen, A Rahdar, N Ebrahimi, ... Chemico-biological interactions 361, 109964, 2022 | 49 | 2022 |
| Parkinson’s disease and COVID-19: A systematic review and meta-analysis RJ Khoshnood, A Zali, A Tafreshinejad, M Ghajarzadeh, N Ebrahimi, ... Neurological Sciences, 1-9, 2022 | 31 | 2022 |
| Advances in nanotechnology versus stem cell therapy for the theranostics of Huntington's disease G Mustafa, D Hassan, M Zeeshan, G Ruiz-Pulido, N Ebrahimi, ... Journal of Drug Delivery Science and Technology 87, 104774, 2023 | 27 | 2023 |
| Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT) M Tangsiri, A Hheidari, M Liaghat, M Razlansari, N Ebrahimi, A Akbari, ... Biomedicine & Pharmacotherapy 170, 115973, 2024 | 26 | 2024 |
| COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis M Barzegar, O Mirmosayyeb, N Ebrahimi, S Bagherieh, A Afshari-Safavi, ... Multiple Sclerosis and Related Disorders 57, 103359, 2022 | 22 | 2022 |
| Prevalence of dysphagia in patients with multiple sclerosis: a systematic review and meta-analysis O Mirmosayyeb, N Ebrahimi, A Shekarian, A Afshari-Safavi, ... Journal of Clinical Neuroscience 108, 84-94, 2023 | 18 | 2023 |
| Immunologic tumor microenvironment modulators for turning cold tumors hot GR Khosravi, S Mostafavi, S Bastan, N Ebrahimi, RS Gharibvand, ... Cancer Communications, 2024 | 15 | 2024 |
| Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis O Mirmosayyeb, N Ebrahimi, M Barzegar, A Afshari-Safavi, S Bagherieh, ... PLoS One 17 (4), e0266492, 2022 | 11 | 2022 |
| Hearing loss among patients with multiple sclerosis (PwMS): A systematic review and meta-analysis O Mirmosayyeb, M Naderi, S Raeisi, N Ebrahimi, EM Ghaffary, ... Multiple sclerosis and related disorders 62, 103754, 2022 | 9 | 2022 |
| Advances in nanotechnology versus stem cell therapy for the theranostics of multiple sclerosis disease AR Damavandi, O Mirmosayyeb, N Ebrahimi, H Zalpoor, P Khalilian, ... Applied Nanoscience 13 (6), 4043-4073, 2023 | 8 | 2023 |
| Prevalence and risk of developing sexual dysfunction in women with multiple sclerosis (MS): a systematic review and meta-analysis A Yazdani, N Ebrahimi, O Mirmosayyeb, M Ghajarzadeh BMC Women's Health 23 (1), 352, 2023 | 7 | 2023 |
| The prevalence of myocardial infarction among multiple sclerosis patients: a systematic review and meta-analysis MJ Tavallaei, AH Tavallaei, N Ebrahimi, H Ghoshouni, A Afshari-Safavi, ... Multiple sclerosis and related disorders 56, 103292, 2021 | 7 | 2021 |
| Stem cell treatment and cerebral palsy: a systematic review and meta-analysis M Motavaf, S Dehghan, M Ghajarzadeh, N Ebrahimi, A Zali, S Safari, ... Current Stem Cell Research & Therapy 19 (2), 210-219, 2024 | 6 | 2024 |
| CNS demyelinating disease following inactivated or viral vector SARS-CoV-2 vaccines: a case series N Ebrahimi, M Mazdak, V Shaygannejad, O Mirmosayyeb Vaccine 41 (5), 1003-1008, 2023 | 6 | 2023 |
| The prevalence of restless legs syndrome (RLS) in patients with multiple sclerosis (MS): A systematic review and meta-analysis—An update A Zali, M Motavaf, S Safari, N Ebrahimi, M Ghajarzadeh, RJ Khoshnood, ... Neurological Sciences 44 (1), 67-82, 2023 | 6 | 2023 |
| Human papillomavirus vaccination in low-and middle-income countries: progression, barriers, and future prospective. Front Immunol. 2023; 14 (May): 1150238 N Ebrahimi, Z Yousefi, G Khosravi, FE Malayeri, M Golabi, M Askarzadeh, ... doi. org/10.3389/fimmu, 2023 | 5 | 2023 |
| Insights into the interplay between Epstein‐Barr virus (EBV) and multiple sclerosis (MS): A state‐of‐the‐art review and implications for vaccine development M Mohammadzamani, K Kazemzadeh, S Chand, S Thapa, N Ebrahimi, ... Health Science Reports 7 (2), e1898, 2024 | 4 | 2024 |
| The burden of rheumatoid arthritis and low back pain in North Africa and Middle East from 1990 to 2019: Results from the Global Burden of Disease Study 2019 M Sanjari, S Noorali, AH Behnoush, S Saeedi Moghaddam, N Fahimfar, ... International Journal of Rheumatic Diseases 26 (11), 2170-2182, 2023 | 2 | 2023 |
| Cerebellitis following COVID-19 infection: A case-based systematic review and pooled analysis S Najdaghi, DN Davani, M Hashemian, N Ebrahimi Heliyon 10 (14), 2024 | 1 | 2024 |
AliReza Afshari SafaviNorth Khorasan University of Medical ScienceVerifisert e-postadresse på nkums.ac.ir
